UTHR United Therapeutics Corporation

$312.23

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 8/22/2025

About United Therapeutics Corporation

United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.

Website: https://www.unither.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1082554
Address
1040 SPRING ST, SILVER SPRING, MD, US
Valuation
Market Cap
$12.79B
P/E Ratio
11.56
PEG Ratio
1.44
Price to Book
1.98
Performance
EPS
$24.63
Dividend Yield
Profit Margin
41.50%
ROE
19.20%
Technicals
50D MA
$320.06
200D MA
$345.84
52W High
$417.81
52W Low
$233.28
Fundamentals
Shares Outstanding
45M
Target Price
$394.93
Beta
0.63

UTHR EPS Estimates vs Actual

Estimated
Actual

UTHR News & Sentiment

Aug 13, 2025 • Benzinga NEUTRAL
Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers - DDD - 3D Sys ( NYSE:DDD )
NEW YORK, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against 3D Systems Corporation ( "3D Systems" or the "Company" ) DDD and certain officers.
Aug 12, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update
MORRISVILLE, N.C., Aug. 12, 2025 ( GLOBE NEWSWIRE ) -- Liquidia Corporation ( NASDAQ: LQDA ) , a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, today announced its financial results for the second quarter ended June 30, 2025.
Aug 11, 2025 • Benzinga NEUTRAL
Lost Money on 3D Systems Corporation ( DDD ) ? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - 3D Sys ( NYSE:DDD )
NEW YORK, Aug. 11, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ( "3D Systems Corporation" or the "Company" ) DDD of a class action securities lawsuit.
Aug 11, 2025 • GlobeNewswire SOMEWHAT-BULLISH
3D Systems Reports Second Quarter 2025 Financial Results
ROCK HILL, S.C., Aug. 11, 2025 ( GLOBE NEWSWIRE ) -- 3D Systems Corporation ( NYSE:DDD ) announced today its financial results for the second quarter ended June 30, 2025.
Aug 11, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?
MRK trims its 2025 sales range but lifts the lower end of its EPS outlook. Keytruda, Animal Health and new drugs are expected to drive a second-half rebound.
Aug 10, 2025 • Benzinga NEUTRAL
DDD FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages 3D Systems Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 12 Deadline in Securities Class Action - DDD - 3D Sys ( NYSE:DDD )
NEW YORK, Aug. 10, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of 3D Systems Corporation DDD between August 13, 2024 and May 12, 2025, both dates inclusive ( the "Class Period" ) , of the important August 12, 2025 lead ...
Sentiment Snapshot

Average Sentiment Score:

0.210
50 articles with scored sentiment

Overall Sentiment:

Bullish

UTHR Reported Earnings

Apr 29, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $6.66
  • Whisper:
  • Surprise %: 0.0%
Feb 19, 2025
Dec 31, 2024 (Pre market)
-0.08 Surprise
  • Reported EPS: $6.19
  • Estimate: $6.27
  • Whisper:
  • Surprise %: -1.2%
Oct 30, 2024
Sep 30, 2024 (Pre market)
-0.04 Surprise
  • Reported EPS: $6.39
  • Estimate: $6.43
  • Whisper:
  • Surprise %: -0.6%
Jul 31, 2024
Jun 30, 2024 (Pre market)
-0.55 Surprise
  • Reported EPS: $5.85
  • Estimate: $6.40
  • Whisper:
  • Surprise %: -8.6%
May 01, 2024
Mar 31, 2024 (Pre market)
0.52 Surprise
  • Reported EPS: $6.17
  • Estimate: $5.65
  • Whisper:
  • Surprise %: 9.2%
Feb 21, 2024
Dec 31, 2023 (Pre market)
0.17 Surprise
  • Reported EPS: $4.36
  • Estimate: $4.19
  • Whisper:
  • Surprise %: 4.1%
Nov 01, 2023
Sep 30, 2023 (Pre market)
0.34 Surprise
  • Reported EPS: $5.38
  • Estimate: $5.04
  • Whisper:
  • Surprise %: 6.8%
Aug 02, 2023
Jun 30, 2023 (Pre market)
0.73 Surprise
  • Reported EPS: $5.24
  • Estimate: $4.51
  • Whisper:
  • Surprise %: 16.2%
May 03, 2023
Mar 31, 2023 (Pre market)
0.34 Surprise
  • Reported EPS: $4.86
  • Estimate: $4.52
  • Whisper:
  • Surprise %: 7.5%

Financials